Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 1,942.00
-13.00 (-0.66%)
May 13, 2025, 2:04 PM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 4.31 billion as of May 13, 2025. Its market cap has increased by 0.63% in one year.
Market Cap
4.31B
Enterprise Value
5.19B
Revenue
2.50B
Ranking
n/a
PE Ratio
15.20
Stock Price
1,942.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 4.31B, an increase of 817.61%. That is a compound annual growth rate of 12.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.39B |
| Oxford Nanopore Technologies | 1.23B |